Trimethylamine- N -oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
Authors:
Open Access
- 1 July 2025
- journal article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1)
Abstract
This study reviews the different steps involved in trimethylamine-N-oxide (TMAO) formation, a gut microbiota (GM)-derived compound that promotes cardiovascular and chronic kidney disease. The formation of TMAO is a metaorganismal process, where trimethylamine (TMA), produced from the dietary precursors betaine, L-carnitine and choline by various members of GM, is absorbed and subsequently oxidized by hepatic flavin-containing monooxygenases before entering the circulation. We provide an updated database on members of GM exhibiting different biochemical pathways and give comprehensive insights into tested as well as hypothetical treatment options to reduce TMAO concentrations in the body. Different angles involving nutrition, TMA-producing bacteria, and their enzymes, as well as host enzymes, are discussed. The study underlines the importance to design personalized therapies taking individual features, such as dietary habits and GM composition, into account. Given the multistep nature of TMAO formation, individualized precision multi-target strategies, for instance, reducing dietary precursors in combination with specific modulations of GM limiting growth/activity of TMA-producing bacteria, might be most successful.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (456214861)
This publication has 149 references indexed in Scilit:
- Glycine reductase mechanismCurrent Opinion in Chemical Biology, 2004
- In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indolesBiochemical Pharmacology, 1999
- CARNITINE METABOLISM AND ITS REGULATION IN MICROORGANISMS AND MAMMALSAnnual Review of Nutrition, 1998
- TMAO anaerobic respiration in Escherichia coli: involvement of the tor operonMolecular Microbiology, 1994
- Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxideBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Conversion of Dietary Choline to Trimethylamine and Dimethylamine in Rats: Dose-Response RelationshipThe Journal of Nutrition, 1989
- Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: A pharmacogenetic approachClinical Pharmacology & Therapeutics, 1987
- BACTERIAL REDUCTION OF TRIMETHYLAMINE OXIDEAnnual Review of Microbiology, 1985
- Betaine: New Oxidant in the Stickland Reaction and Methanogenesis from Betaine and l -Alanine by a Clostridium sporogenes-Methanosarcina barkeri CocultureApplied and Environmental Microbiology, 1983
- Utilization of trimethylamine and other N-methyl compounds for growth and methane formation by Methanosarcina barkeri.Proceedings of the National Academy of Sciences, 1979